secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2022-02-03T23:59:59+00:00
Accession:  0001022079-22-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics Q4 revenue down 8.6%, FY record $10.8B; raises dividend 6.5%; FY2022 guide adj EPS $8.65-$9.35
--------------------------------------------------------------------------------

- Fourth quarter revenues $2.74B (-8.6% YoY); diluted EPS $3.12 reported, $3.33 adjusted (-25.7% adj.).
- Full year 2021 revenues $10.79B (+14.3%); diluted EPS $15.55 reported, $14.24 adjusted (+27.4% adj.).
- Board increased quarterly dividend 6.5% to $0.66/share, payable April 20, 2022, record April 6, 2022.
- FY2022 guidance: revenues $9.0-$9.5B, adj. diluted EPS $8.65-$9.35; base business revenue growth 3.5%-6.0%.
- Cash from operations FY2021 $2.23B (+11.4% YoY); FY2022 cash from operations guided at least $1.6B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207922000008/0001022079-22-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207922000008/dgx-20220203.htm
  HTML page:      https://secwatch.observer/filing/0001022079-22-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer